These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21320056)

  • 1. Discovery of modulators of protein-protein interactions: current approaches and limitations.
    Meireles LM; Mustata G
    Curr Top Med Chem; 2011; 11(3):248-57. PubMed ID: 21320056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating protein-protein interactions: the potential of peptides.
    Nevola L; Giralt E
    Chem Commun (Camb); 2015 Feb; 51(16):3302-15. PubMed ID: 25578807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulators of 14-3-3 Protein-Protein Interactions.
    Stevers LM; Sijbesma E; Botta M; MacKintosh C; Obsil T; Landrieu I; Cau Y; Wilson AJ; Karawajczyk A; Eickhoff J; Davis J; Hann M; O'Mahony G; Doveston RG; Brunsveld L; Ottmann C
    J Med Chem; 2018 May; 61(9):3755-3778. PubMed ID: 28968506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focusing on shared subpockets - new developments in fragment-based drug discovery.
    Abdelraheem EM; Camacho CJ; Dömling A
    Expert Opin Drug Discov; 2015; 10(11):1179-87. PubMed ID: 26296101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational approaches for the design of modulators targeting protein-protein interactions.
    Rehman AU; Khurshid B; Ali Y; Rasheed S; Wadood A; Ng HL; Chen HF; Wei Z; Luo R; Zhang J
    Expert Opin Drug Discov; 2023 Mar; 18(3):315-333. PubMed ID: 36715303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving small molecule virtual screening strategies for the next generation of therapeutics.
    Wingert BM; Camacho CJ
    Curr Opin Chem Biol; 2018 Jun; 44():87-92. PubMed ID: 29920436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benchmark Study Based on 2P2I
    Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T
    J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-Protein Interaction Modulators for Epigenetic Therapies.
    Díaz-Eufracio BI; Naveja JJ; Medina-Franco JL
    Adv Protein Chem Struct Biol; 2018; 110():65-84. PubMed ID: 29413000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives.
    Leifer BS; Doyle SK; Richters A; Evans HL; Koehler AN
    Methods Enzymol; 2018; 610():191-218. PubMed ID: 30390799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting druggable binding sites at the protein-protein interface.
    Fuller JC; Burgoyne NJ; Jackson RM
    Drug Discov Today; 2009 Feb; 14(3-4):155-61. PubMed ID: 19041415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in Discovering Drugs That Target the Protein-Protein Interactions of Disordered Proteins.
    Oláh J; Szénási T; Lehotzky A; Norris V; Ovádi J
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein structure and computational drug discovery.
    Nero TL; Parker MW; Morton CJ
    Biochem Soc Trans; 2018 Oct; 46(5):1367-1379. PubMed ID: 30242117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for targeting protein-protein interactions with synthetic agents.
    Yin H; Hamilton AD
    Angew Chem Int Ed Engl; 2005 Jul; 44(27):4130-63. PubMed ID: 15954154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in discovering small molecules to probe protein function in a systems context.
    Doyle SK; Pop MS; Evans HL; Koehler AN
    Curr Opin Chem Biol; 2016 Feb; 30():28-36. PubMed ID: 26615565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biophysical and computational fragment-based approaches to targeting protein-protein interactions: applications in structure-guided drug discovery.
    Winter A; Higueruelo AP; Marsh M; Sigurdardottir A; Pitt WR; Blundell TL
    Q Rev Biophys; 2012 Nov; 45(4):383-426. PubMed ID: 22971516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying modulators of protein-protein interactions using photonic crystal biosensors.
    Heeres JT; Kim SH; Leslie BJ; Lidstone EA; Cunningham BT; Hergenrother PJ
    J Am Chem Soc; 2009 Dec; 131(51):18202-3. PubMed ID: 19968284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry for fragment screening.
    Chan DS; Whitehouse AJ; Coyne AG; Abell C
    Essays Biochem; 2017 Nov; 61(5):465-473. PubMed ID: 28986384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment-based approaches in drug discovery and chemical biology.
    Scott DE; Coyne AG; Hudson SA; Abell C
    Biochemistry; 2012 Jun; 51(25):4990-5003. PubMed ID: 22697260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein interface pharmacophore mapping tools for small molecule protein: protein interaction inhibitor discovery.
    Voet A; Banwell EF; Sahu KK; Heddle JG; Zhang KY
    Curr Top Med Chem; 2013; 13(9):989-1001. PubMed ID: 23651479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.